Author/Authors :
Agaba, E. I. Jos University Teaching Hospital - Renal Unit, Department of Medicine, Nigeria , Puepet, F. H. Jos University Teaching Hospital - Endocrinology Unit, Department of Medicine, Nigeria , Ugoya, S. O. Jos University Teaching Hospital - Endocrinology Unit, Department of Medicine, Nigeria , Agaba, P. A. Jos University Teaching Hospital - Nigeria Center - AIDS Preventive Initiative, Nigeria , Adabe, R. Jos University Teaching Hospital - Renal Unit, Department of Medicine, Nigeria , Duguru, M. Jos University Teaching Hospital - Renal Unit, Department of Medicine, Nigeria , Rowland, A. I. Jos University Teaching Hospital - Endocrinology Unit, Department of Medicine, Nigeria
Abstract :
Background: Type 2 diabetes (T2D) is a major cause of chronic kidney disease. Control of hypertension and the use of angiotensin converting enzyme inhibitors (ACEI) and/or angiotensin II receptor blockers especially in those with proteinuria have been shown to protect against chronic kidney disease and delay its progression to kidney failure. Methods: We reviewed the medical records of 169 patients at 12 months with a view of auditing the screening for chronic kidney disease and the use of renoprotective measures. Results: Urinalysis was done in 49.1% and serum creatinine in 50.3%. No patient had glomerular filtration rate estimated. Seventy nine (67.6%) of the hypertensive patients were on anti-hypertensives. ACEI was used in 49 (45.8%) of these patients BP control was optimal in 29.1%. Conclusion: There is poor adherence to guidelines on chronic kidney disease screening and renoprotection in T2D.
